GlassScriptPhysician profile
Jonathan A Nickel
NPI 1225007826
$1,162.07
in general payments reported to CMS, 2019-2025
11 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $98.91 · 2021: $28.20 · 2022: $170 · 2023: $333 · 2024: $227 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $558.54 | 2020-2025 | Argos, Clareon, Centurion |
| Allergan, INC. | $156.62 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $144.40 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Abbvie INC. | $105.50 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $52.10 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $51.38 | 2019-2024 | Tecnis Iol, Tecnis Simplicity |
| Genzyme Corporation | $29.72 | 2023 | |
| Sun Pharmaceutical Industries INC. | $18.80 | 2025 | |
| Kala Pharmaceuticals, INC. | $16.31 | 2019 | |
| Ocular Therapeutix, INC. | $14.39 | 2022 | |
| Oyster Point Pharma, INC. | $14.31 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nickel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.